Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population (Q58561861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

title

Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

main subject

papillary thyroid cancer

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Marilena Argyropoulou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

Aristidis S Veskoukis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

Pagona-Maria Karanatsiou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

Aikaterini Manolakelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

Ifigenia Kostoglou-Athanassiou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

George Vilaras

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

Andreas Karameris

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

25 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

Pathology and Oncology Research

30 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

347-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions, with particular emphasis on the follicular variant

30 April 2020

cites work

1 reference

12 December 2020

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

1 reference

12 December 2020

Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations

1 reference

12 December 2020

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

12 December 2020

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

12 December 2020

1 reference

12 December 2020

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 reference

12 December 2020

BRAF mutation in thyroid cancer

1 reference

12 December 2020

Alterations of the BRAF gene in thyroid tumors.

1 reference

12 December 2020

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).

1 reference

12 December 2020

BRAF(V600E) mutation and the biology of papillary thyroid cancer

1 reference

12 December 2020

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.

1 reference

12 December 2020

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer

1 reference

12 December 2020

Molecular genetics and diagnosis of thyroid cancer

1 reference

12 December 2020

A comprehensive survey of Ras mutations in cancer

1 reference

12 December 2020

BRAF mutations in thyroid tumors from an ethnically diverse group

1 reference

12 December 2020

TERT promoter mutations in familial and sporadic melanoma

1 reference

12 December 2020

Highly recurrent TERT promoter mutations in human melanoma

1 reference

12 December 2020

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

1 reference

12 December 2020

Progress in molecular-based management of differentiated thyroid cancer

1 reference

12 December 2020

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

1 reference

12 December 2020

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

1 reference

12 December 2020

Frequency of TERT promoter mutations in human cancers

1 reference

12 December 2020

Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population

1 reference

12 December 2020

The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations

1 reference

12 December 2020

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

1 reference

12 December 2020

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer

1 reference

12 December 2020

TERT promoter mutations in cancer development

1 reference

12 December 2020

NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma

1 reference

12 December 2020

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence

1 reference

12 December 2020

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

1 reference

12 December 2020

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians

1 reference

12 December 2020

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.

1 reference

12 December 2020

TERT promoter mutations in thyroid cancer

1 reference

12 December 2020

Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma

1 reference

12 December 2020

BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients

1 reference

12 December 2020

Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer.

1 reference

12 December 2020

NADPH Oxidase NOX4 Is a Critical Mediator of BRAFV600E-Induced Downregulation of the Sodium/Iodide Symporter in Papillary Thyroid Carcinomas.

1 reference

12 December 2020

10.1007/S12253-018-0497-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361901 AND SRC:MED&resulttype=core&format=json

30 April 2020

1 reference